title: Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT).
authors.forename: K
authors.initials: K
authors.lastname: Ramasamy
authors.forename: Z Y
authors.initials: ZY
authors.lastname: Lim
authors.forename: A
authors.initials: A
authors.lastname: Pagliuca
authors.forename: R
authors.initials: R
authors.lastname: Grundy
authors.forename: S
authors.initials: S
authors.lastname: Devereux
authors.forename: A Y L
authors.initials: AY
authors.lastname: Ho
authors.forename: G J
authors.initials: GJ
authors.lastname: Mufti
mesh_terms: D000328:Adult; D000368:Aged; D003937:Diagnosis, Differential; D018572:Disease-Free Survival; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006086:Graft vs Host Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology* / Q000401:mortality; D019337:Hematologic Neoplasms / Q000150:complications / Q000401:mortality / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015994:Incidence; D008107:Liver Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011089:Polydeoxyribonucleotides / Q000008:administration & dosage*; D013997:Time Factors; D019172:Transplantation Conditioning / Q000009:adverse effects*; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D014652:Vascular Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology* / Q000401:mortality
chemical_list: D005343:Fibrinolytic Agents; D011089:Polydeoxyribonucleotides; C036901:defibrotide